dc.identifier.uri |
http://dx.doi.org/10.15488/17402 |
|
dc.identifier.uri |
https://www.repo.uni-hannover.de/handle/123456789/17532 |
|
dc.contributor.author |
Ma, Huilong
|
eng |
dc.date.accessioned |
2024-05-24T06:59:15Z |
|
dc.date.available |
2024-05-24T06:59:15Z |
|
dc.date.issued |
2024 |
|
dc.identifier.citation |
Ma, Huilong: Medicinal chemistry optimization and mode of action studies of compounds for the treatment of IPF and other fibrotic diseases. Hannover : Gottfried Wilhelm Leibniz Universität, Diss., 2024, X, 11-649 S., DOI: https://doi.org/10.15488/17402 |
eng |
dc.language.iso |
eng |
eng |
dc.publisher |
Hannover : Institutionelles Repositorium der Leibniz Universität Hannover |
|
dc.rights |
CC BY 3.0 DE |
eng |
dc.rights.uri |
http://creativecommons.org/licenses/by/3.0/de/ |
eng |
dc.subject |
Tranilast |
eng |
dc.subject |
contains research data |
eng |
dc.subject |
anti-fibrotic activity |
eng |
dc.subject |
photolabeling |
eng |
dc.subject |
target identification |
eng |
dc.subject |
PET |
eng |
dc.subject |
targeted drug release |
eng |
dc.subject |
Tranilast |
ger |
dc.subject |
antifibrotsiche Aktivität |
ger |
dc.subject |
Target Identifizierung |
ger |
dc.subject |
zielgerichtete Wirkstofffreisetzung |
ger |
dc.subject |
enthält Forschungsdaten |
ger |
dc.subject.ddc |
500 | Naturwissenschaften
|
eng |
dc.title |
Medicinal chemistry optimization and mode of action studies of compounds for the treatment of IPF and other fibrotic diseases |
eng |
dc.type |
DoctoralThesis |
eng |
dc.type |
Text |
eng |
dc.description.version |
publishedVersion |
eng |
tib.accessRights |
Verlagsembargo bis zum 2025-12-31, danach frei zug�nglich |
eng |